Popular Articles

Easier Way To Identify A Child's High Blood Pressure Created By Pediatrician
Pediatricians now have a new and simple way to diagnose a serious problem facing our nation"s children - thanks to David Kaelber, M.D., Ph.D., M.P.H., MetroHealth System pediatrician, internist, and chief medical informatics officer and Case Western Reserve University School of Medicine researcher and faculty member. Nearly 75% of cases of hypertension and 90% of cases of prehypertension in children and adolescents go undiagnosed. These troubling statistics were documented in previously published research by Dr. Kaelber. From this research, Dr. Kaelber and fellow researchers felt that one of the main reasons for the under-diagnosis may be due to the complex chart currently used to help physicians and medical personnel identify high blood pressure in children. So Dr. Kaelber"s team simplified the chart - focusing solely on a child"s age and gender - eliminating the need for a height percentile and reducing the number of values in the blood pressure table from 476 to just 64. The revised chart and accompanying description are published in the June issue of the journal Pediatrics.
generic viagra online
British Medical Association Scotland Calls For An End To The Ridiculous Pricing Of Alcohol
Doctors leaders called for an end to the ridiculous pricing of alcohol for off sales in light of findings from the Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS).
News of the day
Eurand Successfully Completes Registration Procedure For Paracetamol ODT 250 And 500 Mg In The European Union
Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced that the Dutch Medicines Evaluation Board (MEB) informed the Company that the Decentralized Procedure (DCP) for registration of Paracetamol 250 and 500 mg Orodispersible Tablets (ODT) in several EU countries has been successfully completed.
Oncology

Kai Sensors Receives FDA Clearance For Its Wireless, Non-Contact Respiratory Device

Hawaii-based Kai Sensors announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kai Sensors Non-Contact Respiratory Rate Spot Check, also called the Kai RSpot. The 510(k) clearance allows Kai Sensors to market the Kai RSpot to physicians, hospitals, and clinics. The Kai RSpot is a device that offers a practical and effective approach of measuring respiratory rate in hospital and clinical settings. The device is easy to use and works wirelessly, with no contact or attachment to the patient. Due to difficulties with current approaches of measuring respiratory rate, this important vital sign is often measured infrequently, inaccurately, inconsistently, or not at all. The clinically tested Kai RSpot provides a solution that addresses many of the shortcomings of existing technologies, and will enable doctors and health care professionals to measure a patient"s respiration with greater ease and with increased regularity. "The 510(k) approval from the FDA is a major milestone for Kai Sensors that will enable our Company to continue to grow," said Kai Sensors CEO Andrea Yuen. "We believe the Kai RSpot will make collecting respiratory information easier for physicians and clinicians and thus help increase the amount of information available about a patient and improve the overall quality of health care." Kai Sensors, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):